title: [Clinical significance of treatment for dyslipidemia in CKD].
authors.forename: Atsuko
authors.initials: A
authors.lastname: Ikemori
authors.forename: Kenjiro
authors.initials: K
authors.lastname: Kimura
mesh_terms: D001384:Azetidines / Q000008:administration & dosage; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D002784:Cholesterol / Q000378:metabolism; D018450:Disease Progression; D004338:Drug Combinations; D050171:Dyslipidemias / Q000188:drug therapy* / Q000209:etiology* / Q000378:metabolism; D000069499:Ezetimibe, Simvastatin Drug Combination; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D007678:Kidney Glomerulus / Q000473:pathology; D007684:Kidney Tubules / Q000473:pathology; D008074:Lipoproteins / Q000378:metabolism; D051436:Renal Insufficiency, Chronic / Q000209:etiology* / Q000473:pathology / Q000517:prevention & control; D012307:Risk Factors; D019821:Simvastatin / Q000008:administration & dosage
chemical_list: D001384:Azetidines; D004338:Drug Combinations; D000069499:Ezetimibe, Simvastatin Drug Combination; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008074:Lipoproteins; D002784:Cholesterol; D019821:Simvastatin